Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

AIM: This study was designed to evaluate the efficacy and toxicities of concomitant boost intensity-modulated radiation therapy (IMRT) along with capecitabine and oxaliplatin, followed by a cycle of Xelox, in neoadjuvant course for locally advanced rectal cancer. MATERIALS AND METHODS: Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ji, Liu, Fangqi, Gu, Weilie, Lian, Peng, Sheng, Weiqi, Xu, Junyan, Cai, Gang, Shi, Debing, Cai, Sanjun, Zhang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984733/
https://www.ncbi.nlm.nih.gov/pubmed/24606870
http://dx.doi.org/10.1186/1748-717X-9-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984733/
https://www.ncbi.nlm.nih.gov/pubmed/24606870
http://dx.doi.org/10.1186/1748-717X-9-70

Ejemplares similares